481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Keyword(s):
2011 ◽
Vol 106
◽
pp. S113-S114
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 54
◽
pp. S167-S168
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 54
◽
pp. S173-S174
◽
Keyword(s):
Keyword(s):
Keyword(s):